Smiling professional working at a laptop
Who We Serve

Protection for your people. Protection for your plan.

Employers, health plans, brokers, government programs, and PBM partners come to PharmPix under different pressures, but at the same moment: before avoidable cost, clinical risk, or member disruption becomes permanent.

The Whole Pharmacy Picture

The best time to fix a pharmacy problem is before it becomes one.

A duplicate therapy, a risky combination, a 90-day fill for a medication the member stops in week two. Caught early, these are small corrections. Caught late, they're cost, disruption, and harm. PharmPix is proactive by design.

Who We Work With

Our model flexes. Our clinical rigor doesn't.

Self-funded employers protecting a budget. Health plans protecting a margin. Brokers protecting a reputation. Government programs protecting compliance. PBM partners protecting a brand.

Different pressures, one foundation under all of it: proactive clinical intelligence working to protect plans and their members.

Health Plans

Utilization is the lever a plan actually controls. PharmPix manages it in real time through clinical oversight at adjudication, while our formulary, P&T, and specialty teams work as an extension of yours.

•

Protect utilization in real time, at the point of adjudication

•

Correct duplicative and inappropriate therapy before it pays

•

Capture biosimilar and generic opportunity with clinical precision

•

Lower net cost without closing the formulary

OneArk® for Health Plans
Self-Funded Employers & Unions

Avoidable cost builds quietly all year: in waste, in drug-related problems, in benefit design that isn't keeping up with how your population actually uses it. We surface it and act on it months before it becomes the number on the page.

•

See what's actually driving spend

•

Manage GLP-1 and specialty trend with clinical judgment

•

Prevent avoidable cost

•

Keep members on therapy

Explore Clinical Intelligence
Brokers & Consultants

Real answers for the questions your clients are asking. What's driving specialty spend? Should we cover GLP-1s? What's actually behind the rebate number? PharmPix gives you concrete answers to bring into the conversation, and performance that holds up after the sale.

•

30–40% average specialty savings

•

GLP-1 and biosimilar strategies with clinical guidance

•

Pass-through pricing and no owned pharmacies

•

Reporting that holds up at renewal

Reprocess with Us
Government & Medicare Programs

Regulatory change, audit cycles, quality requirements, tight budgets. Every year, all at once. MedArk™ was built inside that reality, pairing Medicare-specific technology with the clinical and operational depth public programs demand.

•

Support Part D compliance and STARS performance

•

Stay audit-ready by design

•

Manage formulary, clinical, and quality requirements as one system

•

Adapt as regulations and program needs change

Explore MedArk™
PBMs & Platform Partners

OneArk® runs under your brand and configures around your business: complex designs, third-party integrations, disaggregated models, so you can grow at your pace, with your name on the work.

•

Launch or expand white-label solutions under your own brand

•

Configure complex benefits without custom development cycles

•

Support modular and disaggregated operating models

•

Scale while keeping full ownership of your client relationships

White-Label Opportunities
Adjudication Protection

The technology behind the whole pharmacy picture

OneArk® runs beneath every claim, catching clinical risk and enforcing benefit integrity before it becomes a paid claim, a safety issue, or a cost no one saw coming.

Smiling professional working at a computer

“We moved from a big-three PBM and finally have transparency we can show our finance team. The clinical side was the bonus we didn't expect.”

Colleagues discussing documents in a conference room
VP, Total Rewards
Self-funded employer, 9,000 lives
Bring It Into Focus

See what changes when the whole pharmacy picture comes into focus.

We'll show you where avoidable cost and clinical risk are sitting in your benefit, and what protecting both looks like.